Riskpilot← Back to searchSign inGet full accessTERAPIL AS
ASActiveOrg 923314342Ingolfs Vei 43, 1385 AskerPhysiotherapy activities · NACE 8695Est. 20191 employees
Revenue 2024
NOK 226K
-55% vs 2023
EBITDA margin
-18.0%
-185% vs 2023
Equity ratio
-18.1%
Financial strength
Net profit 2024
NOK -43K
-199% vs 2023
| Revenue | NOK 226K | -55% |
| EBITDA | NOK -41K | -185% |
| Net profit | NOK -43K | -199% |
| Total assets | NOK 419K | +5% |
| Equity | NOK -76K | -132% |
| Employees | 1 | — |
Legal name
TERAPIL AS
Org number
923314342
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
2. september 2019
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap eller daglig leder alene.
Company purpose
Bidra til å bedre livskvaliteten til de som kommer inn døra.
Address
Ingolfs Vei 43, 1385 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 102 | 148 | 348 | 502 | 226 |
| Staff expenses | −61 | −55 | −206 | −473 | −166 |
| EBITDA | 2 | −4 | −16 | −14 | −41 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 2 | −4 | −16 | −14 | −41 |
| Net financials | 0 | 0 | 0 | −0 | −2 |
| Profit before tax | 2 | −4 | −16 | −14 | −43 |
| Tax | 0 | −0 | −0 | −0 | −0 |
| Net profit | 1 | −4 | −16 | −14 | −43 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 0 | 11 | 349 | 397 | 419 |
| Equity | 1 | −3 | −18 | −33 | −76 |
| Long-term debt | 0 | 0 | 0 | 339 | 384 |
| Short-term debt | 0 | 14 | 367 | 91 | 111 |
| Total debt | 0 | 14 | 367 | 430 | 495 |
EBITDA margin
-18.0%
This company
15.8%
Market median
-214% vs market
20202024
Equity ratio
-18.1%
This company
38.2%
Market median
-147% vs market
20202024
Return on equity
-4313100.0%
This company
18.4%
Market median
-23440861% vs market
20202024
Net profit margin
-19.1%
This company
8.1%
Market median
-336% vs market
20202024
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
20202024
Debt / equity
6.53×
This company
0.62×
Market median
-953% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MO Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Deputy Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TERAPIL AS 
Asker Kvinnehelse AsBoard members of TERAPIL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mathilde Okkenhaug Pilskog | Chief Executive Officer | 0 companies |
| Lasse Fløtten Gammersvik | Chairman | 0 companies |
| Cathrine Sundt Okkenhaug | Deputy Chairman | 0 companies |